Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up

被引:75
作者
Naver, H [1 ]
Swartling, C
Aquilonius, SM
机构
[1] Univ Uppsala Hosp, Dept Neurol, SE-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Dermatol, SE-75185 Uppsala, Sweden
关键词
botulinum toxin; duration; hyperhidrosis; injection; intradermal; side-effects; sweat; therapy;
D O I
10.1046/j.1468-1331.2000.00014.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Focal hyperhidrosis is a common and sometimes handicapping condition for which the presently most effective treatment, sympathectomy, often leads to irreversible side-effects. We aimed to study effectiveness and tolerability of an alternative treatment with botulinum toxin injections over a period of one year for this condition. Twenty-eight patients with palmar (n = 19) and/or axillary (n = 13) hyperhidrosis were treated with intracutaneous injections of botulinum toxin (Botox(R)) 2 U/4 cm(2). Sweat function was studied clinically and by objective measurements after treatment of one side. Treated and untreated sides, and pre- and post-treatment skin areas were compared. Subjective evaluation was performed after treatment of one side and 2-5 months after treatment of both sides. Duration of effect was controlled by a one-year follow-up. Sweating disappeared in eight out of 13 patients with axillary and in five out of 19 with palmar hyperhidrosis, and was reduced markedly in another five out of 13 and 10 out of 19 patients. Two-thirds of those treated for hand sweat noticed a slight and transient reduction of power of finger grip. No side-effects were noticed after treatment of axillary hyperhidrosis. We find intracutaneous injections of botulinum toxin with this technique safe and effective, and due to the relatively long duration of effect the treatment should be recommended before sympathectomy for focal hyperhidrosis.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 20 条
[11]  
Lin C C, 1992, J Laparoendosc Surg, V2, P1, DOI 10.1089/lps.1992.2.1
[12]  
LIN CC, 1994, EUR J SURG, P43
[13]  
Minor V., 1928, DTSCH Z NERVENHEILKD, V101, P302, DOI 10.1007/BF01652699
[14]   Focal hyperhidrosis -: Effective treatment with intracutaneous botulinum toxin [J].
Naumann, M ;
Hofmann, U ;
Bergmann, I ;
Hamm, H ;
Toyka, KV ;
Reiners, K .
ARCHIVES OF DERMATOLOGY, 1998, 134 (03) :301-304
[15]  
Naver H, 1997, EUR J NEUROL, V4, pS75
[16]   Pharmacologic characterization of botulinum toxin for basic science and medicine [J].
Pearce, LB ;
First, ER ;
MacCallum, RD ;
Gupta, A .
TOXICON, 1997, 35 (09) :1373-1412
[17]   TRANSTHORACIC ENDOSCOPIC SYMPATHECTOMY FOR HYPERHIDROSIS AND RAYNAUDS-PHENOMENON [J].
SAYERS, RD ;
JENNER, RE ;
BARRIE, WW .
EUROPEAN JOURNAL OF VASCULAR SURGERY, 1994, 8 (05) :627-631
[18]   Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms [J].
Schnider, P ;
Binder, M ;
Auff, E ;
Kittler, H ;
Berger, T ;
Wolff, K .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (04) :548-552
[19]   Botulinum toxin therapy for palmar hyperhidrosis [J].
Shelley, WB ;
Talanin, NY ;
Shelley, ED .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (02) :227-229
[20]  
Tugnoli V, 1997, Expert Opin Investig Drugs, V6, P1383, DOI 10.1517/13543784.6.10.1383